Related Experiment Videos
Immunomodulating activity of MDMA
R Pacifici1, P Zuccaro, M Farré
1Clinical Biochemistry Department, Istituto Superiore di Sanità, Roma, Italy.
Abstract:
MDMA (3,4-methylenedioxymethamphetamine) use can cause neurochemical, behavioral and endocrine alterations, similar to those produced by exposure to acute stress, suggesting its potential as a "chemical stressor." It is known that stressful stimuli can produce a depression of immune function and an alteration in immune cells distribution. In vitro exposure to MDMA resulted in a modulation of several immune functional parameters such as T-cell regulatory function, cytotoxic T-lymphocyte activity, natural killer cell activity and macrophage function. Administration of MDMA in rats produced a rapid and sustained suppression of induced lymphocytes proliferation and a significant decrease in circulating lymphocytes. These alterations in rat immune function were accompanied by a significant rapid increase in plasma corticosterone concentrations. It was postulated that the result of altered induced proliferation response of lymphocytes could have been due to a combined effect of direct action of MDMA on lymphocytes and to the activation of the hypothalamic pituitary adrenal axis (HPA axis) and/or the sympathetic nervous system (SNS) via central mechanisms. In humans, acute MDMA treatment produced a time-dependent immune dysfunction associated with MDMA plasma concentrations. Although total leukocyte count remained unchanged, there was a decrease in CD4+ T-cells and functional responsiveness of lymphocytes to mitogenic stimulation, while percentage of natural killer cells significantly increased. A rise of cortisol plasma concentrations similar to that observed in the rat model supported the hypothesis of MDMA-induced release of corticotrophin-releasing factor from the median eminence of the hypothalamus and subsequent HPA axis and SNS activation. The present findings indicate that MDMA ingestion may represent a potential health hazard for an increased risk of immune system-related diseases.
Insights
MDMA (3,4-methylenedioxymethamphetamine) use significantly impairs immune function in both rats and humans, potentially increasing disease risk. This drug acts as a chemical stressor, activating stress response systems and altering immune cell activity.
Area of Science:
- Immunology
- Neuroendocrinology
- Pharmacology
Background:
- 3,4-methylenedioxymethamphetamine (MDMA) acts as a chemical stressor, inducing neurochemical and endocrine changes.
- Stressful stimuli are known to suppress immune function and alter immune cell distribution.
- MDMA's effects on the immune system and stress response pathways require detailed investigation.
Purpose of the Study:
- To investigate the impact of MDMA on immune function and stress response.
- To compare MDMA's effects in a rat model and in humans.
- To elucidate the mechanisms underlying MDMA-induced immune alterations.
Main Methods:
- In vitro and in vivo studies in rats and humans.
- Assessed immune cell function (T-cells, NK cells, macrophages) and lymphocyte proliferation.
- Measured plasma corticosterone and cortisol concentrations.
Main Results:
- MDMA exposure modulated immune cell function in vitro.
- In rats, MDMA suppressed lymphocyte proliferation and decreased circulating lymphocytes, accompanied by increased corticosterone.
- In humans, MDMA caused immune dysfunction, decreased CD4+ T-cells, and increased NK cells, with elevated cortisol, suggesting HPA axis and SNS activation.
Conclusions:
- MDMA ingestion can lead to significant immune system dysfunction.
- MDMA activates the hypothalamic-pituitary-adrenal (HPA) axis and sympathetic nervous system (SNS).
- MDMA use poses a potential health hazard, increasing the risk of immune system-related diseases.